One Payer's Perspective On CER: WellPoint Wants Real-World Applicability
Executive Summary
A key component in the current thinking on comparative effectiveness research is an understanding of how medical treatments are used in real-world settings. From the perspective of one major payer, WellPoint, staying on this course would be a good thing
You may also be interested in...
WellPoint CE Study Results In Coverage Adjustment For Oral Asthma Drugs
WellPoint lifted prior authorization requirements on oral asthma medications based on the results of a comparative effectiveness analysis of claims data for oral and inhaled asthma medications
Real-World Use Is Focus Of Updated Definition Of Comparative Effectiveness
The Federal Coordinating Council for Comparative Effectiveness Research has tweaked its definition of comparative effectiveness to place an emphasis on "real-world" use, as well as improving outcomes
JUPITER Shines Celestial Glow On Statin Use; Docs Ready, But Are Payers?
A few months after the release of AstraZeneca's widely heralded JUPITER Crestor study, physicians seem prepared to prescribe statins more broadly based on that evidence, according to discussion at the American College of Cardiology annual meeting